Philip D. Worboys, SVP, Research & Transl Science at Theravance Biopharma, Inc. (TBPH), sold 8,829 shares at $20.00 ($177K) on 2021-03-09, disclosed to the SEC on 2021-03-11.
Open-market sale of $177k TBPH by SVP, Research & Transl Science. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TBPH | SELL | 2018-09-14 | $364K | — | Filing → |